Skip to main
AHR

AHR Stock Forecast & Price Target

AHR Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 25%
Buy 67%
Hold 8%
Sell 0%
Strong Sell 0%

Bulls say

American Healthcare REIT Inc. (AHR) is poised for significant growth due to its favorable acquisition strategy, with an anticipated additional $600 million in acquisitions by 2026, which will enhance its already diversified healthcare real estate portfolio. The company's key operator, Trilogy, is expected to benefit from improved Medicare Advantage reimbursement rates by enhancing occupancy and enhancing the quality mix, which are both vital for sustaining growth in both senior housing and skilled nursing facilities. Furthermore, AHR's strategic move to lower its cost of capital allows for more aggressive and accretive capital deployment, positioning the company well for stronger organic growth and overall investment performance.

Bears say

American Healthcare REIT faces potential negative pressures due to economic headwinds and regulatory changes that could adversely affect tenant performance, impacting the company’s ability to meet earnings expectations. The company is also exposed to acquisition risks, with anticipated lower initial yields and the possibility of missing organic NOI growth expectations that could further harm stock performance. Additionally, the reliance on skilled nursing facilities for a significant portion of income introduces heightened volatility, leaving the REIT vulnerable to operational challenges and broader market fluctuations.

AHR has been analyzed by 12 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 67% recommend Buy, 8% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of American Healthcare REIT Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About American Healthcare REIT Inc (AHR) Forecast

Analysts have given AHR a Buy based on their latest research and market trends.

According to 12 analysts, AHR has a Buy consensus rating as of Mar 17, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $52.83, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $52.83, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

American Healthcare REIT Inc (AHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.